ViroGates A/S (OCSE:VIRO) Interest Expense : kr-0.72 Mil (TTM As of Mar. 2024)

View and export this data going back to 2018. Start your Free Trial

What is ViroGates A/S Interest Expense?

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. ViroGates A/S's interest expense for the three months ended in Mar. 2024 was kr -0.16 Mil. Its interest expense for the trailing twelve months (TTM) ended in Mar. 2024 was kr-0.72 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. ViroGates A/S's Operating Income for the three months ended in Mar. 2024 was kr -3.71 Mil. ViroGates A/S's Interest Expense for the three months ended in Mar. 2024 was kr -0.16 Mil. ViroGates A/S did not have earnings to cover the interest expense. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

ViroGates A/S Interest Expense Historical Data

The historical data trend for ViroGates A/S's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ViroGates A/S Interest Expense Chart

ViroGates A/S Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Interest Expense

Get a 7-Day Free Trial

-0.30

-0.29

-0.19

-0.11

-0.57

ViroGates A/S Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Interest Expense	Get a 7-Day Free Trial															-0.02	-0.16	-0.21	-0.19	-0.16

ViroGates A/S Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was kr-0.72 Mil.

ViroGates A/S (OCSE:VIRO) Interest Expense Explanation

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

ViroGates A/S's Interest Expense for the three months ended in Mar. 2024 was kr-0.16 Mil. Its Operating Income for the three months ended in Mar. 2024 was kr-3.71 Mil. And its Long-Term Debt & Capital Lease Obligation for the three months ended in Mar. 2024 was kr5.30 Mil.

ViroGates A/S's Interest Coverage for the quarter that ended in Mar. 2024 is calculated as

ViroGates A/S did not have earnings to cover the interest expense.

The higher the ratio, the stronger the company's financial strength is.

ViroGates A/S (OCSE:VIRO) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » ViroGates A/S (OCSE:VIRO) » Definitions » Interest Expense

Comparable Companies

Traded in Other Exchanges

N/A

Address

Banevaenget 13, Birkerod, DNK, DK-3460

Website

https://www.virogates.com

ViroGates A/S is a life science company that develops and sells prognostic products to the healthcare sector. The products are used in hospital emergency services, in particular, to make a clinical decision on hospitalization or discharge of emergency patients. The products can also be used for the prognosis of lifestyle-related diseases such as cardiovascular disease, type 2 diabetes, and cancer. It has developed a product line called suPARnostic to make the suPAR test available as a commercially available test and the ambition is to get the test implemented and used for clinical decision-making.

ViroGates A/S (OCSE:VIRO) Headlines

No Headlines